Senior Director, Head of Department, CMC Late Stage & Development Project Management
Genmab
About this role
The Senior Director, Head of Late-Stage Manufacturing Development Project Management will lead Genmab’s LSMD Project Management team, setting direction for late-stage CMC development and preparing CMC packages for regulatory filings. The role reports to the VP of Late-Stage Manufacturing Development within Tech Ops and involves managing a team of project managers across Genmab’s portfolio. This position shapes CMC strategy, cross-functional alignment, and the development of the project management capability.
Skills
Qualifications
About Genmab
genmab.comIndustries
Healthcare
Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases
Recent company news
First Trust Advisors LP Sells 82,922 Shares of Genmab A/S Sponsored ADR $GMAB
11 hours ago
Narrow-Moat Genmab's Royalty Revenue Maintains Near-Term Growth as Pipeline Advancement Progresses
3 days ago
Transactions in Connection with Share Buy-back Program
3 days ago
Genmab Updates Share Buy-Back Program and Corrects Accumulated Purchase Figures
3 days ago
Genmab Publishes 2025 Annual Report
3 weeks ago
About Genmab
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Genmab.
Salary
$205k – $271k
per year
More jobs at Genmab
Similar Jobs
Global Manufacturing Sciences CMC Lead
Takeda Pharmaceutical Company
Head of Drug Product Development
Ironwood Pharmaceuticals
Vice President, Late-Stage Oncology Clinical Operations
American Association of Physicists in Medicine
Senior Director, CMC Development, Biologics
Flagship Pioneering, Inc.
Vice President, Late Stage Ophthalmology - DME
4D Molecular Therapeutics
Associate Director, Regulatory CMC
Amylyx Pharmaceuticals